Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T J Postma

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Neurology|March 12, 2003
Interobserver variability in the radiological assessment of response to chemotherapy in gliomaM J Vos, B M J Uitdehaag, F Barkhof, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2000
A phase II study of paclitaxel in chemonaïve patients with recurrent high-grade gliomaT J Postma, J J Heimans, S A Luykx, et al.
Seminars in Oncology|August 1, 1995
High-dose paclitaxel with granulocyte colony-stimulating factor in patients with advanced breast cancer refractory to anthracycline therapy: a European Cancer Center trialJ B Vermorken, W W ten Bokkel Huinink, I A Mandjes, et al.
Journal of Cancer Research and Clinical Oncology|January 17, 2004
Lack of neuroprotection by an ACTH (4-9) analogue. A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphomaS Koeppen, C C P Verstappen, R Körte, et al.
Neurology|January 10, 2001
PCV chemotherapy for recurrent glioblastoma multiformeA C Kappelle, T J Postma, M J Taphoorn, et al.
European Journal of Cancer (Oxford, England : 1990)|May 25, 2005
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20T J Postma, N K Aaronson, J J Heimans, et al.
Journal of Neuro-Oncology|February 20, 2019
Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational studyM Kerkhof, J A F Koekkoek, M J Vos, et al.
Journal of Neuro-Oncology|August 25, 2014
Symptoms and medication management in the end of life phase of high-grade glioma patientsJ A F Koekkoek, L Dirven, E M Sizoo, et al.
Journal of Neuro-Oncology|July 13, 2016
Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysisF K Holla, T J Postma, M A Blankenstein, et al.
Neurology|July 10, 2002
Radiotherapy-induced cerebral abnormalities in patients with low-grade gliomaT J Postma, M Klein, C C P Verstappen, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Neurology|March 12, 2003
Interobserver variability in the radiological assessment of response to chemotherapy in gliomaM J Vos, B M J Uitdehaag, F Barkhof, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2000
A phase II study of paclitaxel in chemonaïve patients with recurrent high-grade gliomaT J Postma, J J Heimans, S A Luykx, et al.
Seminars in Oncology|August 1, 1995
High-dose paclitaxel with granulocyte colony-stimulating factor in patients with advanced breast cancer refractory to anthracycline therapy: a European Cancer Center trialJ B Vermorken, W W ten Bokkel Huinink, I A Mandjes, et al.
Journal of Cancer Research and Clinical Oncology|January 17, 2004
Lack of neuroprotection by an ACTH (4-9) analogue. A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphomaS Koeppen, C C P Verstappen, R Körte, et al.
Neurology|January 10, 2001
PCV chemotherapy for recurrent glioblastoma multiformeA C Kappelle, T J Postma, M J Taphoorn, et al.
European Journal of Cancer (Oxford, England : 1990)|May 25, 2005
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20T J Postma, N K Aaronson, J J Heimans, et al.
Journal of Neuro-Oncology|February 20, 2019
Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational studyM Kerkhof, J A F Koekkoek, M J Vos, et al.
Journal of Neuro-Oncology|August 25, 2014
Symptoms and medication management in the end of life phase of high-grade glioma patientsJ A F Koekkoek, L Dirven, E M Sizoo, et al.
Journal of Neuro-Oncology|July 13, 2016
Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysisF K Holla, T J Postma, M A Blankenstein, et al.
Neurology|July 10, 2002
Radiotherapy-induced cerebral abnormalities in patients with low-grade gliomaT J Postma, M Klein, C C P Verstappen, et al.
Pageof 4